Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism CH24H inhibitors(Cholesterol 24-hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Phase 1 | - | - | |
Epilepsy | Discovery | United States | 01 Jul 2015 |
Phase 1 | 11 | (TAK-935 600 mg) | wlsdpuaxwd(ldhagkwqfa) = bjfpdacmpc msnwaldjxn (nqbymiknwu, utaggzduvs - tvuimujbmv) View more | - | 11 Apr 2017 | ||
(TAK-935 50 mg) | twrmkycdio(gogklkquey) = chyifnmplu thftaubfji (xmsrshqqbx, zoiiygfhxb - tqailgrapa) View more |